230 related articles for article (PubMed ID: 31016513)
1. Early Detection of Myelodysplastic Syndrome/Leukemia-associated Mutations Using NGS Is Critical in Treating Aplastic Anemia.
Li X; Wu YH; Cai SS; Li WM; You Y; Zhang M
Curr Med Sci; 2019 Apr; 39(2):217-221. PubMed ID: 31016513
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia.
Lew JL; Fenderson JL; Carmichael MG
Hawaii J Med Public Health; 2017 Nov; 76(11 Suppl 2):10-12. PubMed ID: 29164009
[TBL] [Abstract][Full Text] [Related]
3. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ
Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolution in aplastic anemia.
Afable MG; Tiu RV; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2011; 2011():90-5. PubMed ID: 22160018
[TBL] [Abstract][Full Text] [Related]
6. [Chronologic analysis of clonal evolution in acquired aplastic anemia and sMDS].
Yoshizato T
Rinsho Ketsueki; 2016 Apr; 57(4):430-9. PubMed ID: 27169446
[TBL] [Abstract][Full Text] [Related]
7. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
8. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
Keel SB; Scott A; Sanchez-Bonilla M; Ho PA; Gulsuner S; Pritchard CC; Abkowitz JL; King MC; Walsh T; Shimamura A
Haematologica; 2016 Nov; 101(11):1343-1350. PubMed ID: 27418648
[TBL] [Abstract][Full Text] [Related]
9. Aplastic anemia and clonal evolution: germ line and somatic genetics.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of aplastic anemia and myelodysplastic syndrome.
Paquette RL
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):153-61. PubMed ID: 12380966
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding clonal haematopoiesis in aplastic anaemia.
Stanley N; Olson TS; Babushok DV
Br J Haematol; 2017 May; 177(4):509-525. PubMed ID: 28107566
[TBL] [Abstract][Full Text] [Related]
13. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and Therapy of aplastic anemia - update 2021].
Panse J
Dtsch Med Wochenschr; 2021 Apr; 146(7):451-454. PubMed ID: 33780990
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
Feng BZ; Lei JL; Han JZ
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes.
Matsui WH; Brodsky RA; Smith BD; Borowitz MJ; Jones RJ
Leukemia; 2006 Mar; 20(3):458-62. PubMed ID: 16437138
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia.
Zheng G; Chen P; Pallavajjalla A; Haley L; Gondek L; Dezern A; Ling H; De Marchi F; Lin MT; Gocke C
Am J Hematol; 2019 Oct; 94(10):1141-1148. PubMed ID: 31350794
[TBL] [Abstract][Full Text] [Related]
18. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.
Yoshizato T; Dumitriu B; Hosokawa K; Makishima H; Yoshida K; Townsley D; Sato-Otsubo A; Sato Y; Liu D; Suzuki H; Wu CO; Shiraishi Y; Clemente MJ; Kataoka K; Shiozawa Y; Okuno Y; Chiba K; Tanaka H; Nagata Y; Katagiri T; Kon A; Sanada M; Scheinberg P; Miyano S; Maciejewski JP; Nakao S; Young NS; Ogawa S
N Engl J Med; 2015 Jul; 373(1):35-47. PubMed ID: 26132940
[TBL] [Abstract][Full Text] [Related]
19. Clonal hematopoiesis in acquired aplastic anemia.
Ogawa S
Blood; 2016 Jul; 128(3):337-47. PubMed ID: 27121470
[TBL] [Abstract][Full Text] [Related]
20. Border between aplastic anemia and myelodysplastic syndrome.
Yamazaki H; Nakao S
Int J Hematol; 2013 May; 97(5):558-63. PubMed ID: 23613266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]